Search Results

Clinical Diagnostic Laboratories  invites you to join the conversation about the recent $300,000 in donations received by Luigi Mangione, accused of killing UnitedHealthcare CEO Brian Thompson. This significant amount was raised through a crowdfunding campaign to support Mangione's legal defense. The outpouring of support highlights widespread frustration with the current healthcare system. Many donors expressed their anger towards insurance companies, citing issues such as denied claims and overwhelming medical debt. Mangione's case has become a symbol of the struggle against a system perceived as prioritizing profits over people. Recent reports suggest that insurance providers like United Healthcare and Cigna are denying claims at an increased rate due to faulty AI software. This AI software automatically denies claims without taking certain circumstances into consideration, leading to numerous complaints from patients and healthcare providers. For example, UnitedHealth has been accused of using an AI model with a 90% error rate to deny elderly patients medically necessary coverage. This has resulted in patients being prematurely kicked out of care facilities and forced to deplete their savings to continue receiving necessary medical care. Have you had a bad experience with insurance?  We want to hear your stories and thoughts on the matter. Share your experiences in the comments and join the discussion on how we can improve healthcare for everyone. Disclaimer : Clinical Diagnostic Laboratories does not endorse any particular stance on this issue. We are committed to providing high-quality medical testing services and fostering open dialogue about healthcare challenges. Prevention is the Best Cure: Schedule Your Health Screening Today! At Clinical Diagnostic Laboratories , we believe that taking a proactive approach to your health is the key to a longer, healthier life. Regular health screenings can help detect potential health issues before they become serious, giving you peace of mind and the best chance for successful treatment. Don’t wait for symptoms to appear— schedule your appointment with us today and take the first step towards a healthier future. Our team of experts is here to provide you with comprehensive and accurate medical tests tailored to your individual needs. Remember, prevention is the best cure. Book your health screening now and invest in your well-being!

Services for Life Insurance Companies We Care About Your Applicants Clinical Diagnostics Laboratories cares about your applicants and their goal to acquire life insurance. We promise to provide your life insurance applicants with professional laboratory testing to assist in their application process that is done with dignity. We provide laboratory testing using state-of-the-art testing equipment. With the ability to gain results in 24hrs with easy scheduling options . Our highly skilled professionals are on standby to treat your applicants with the highest degree of care and efficiency. Click here today to get started. Contact Us

Ordering information regarding an HPV Self Collection Screen for Clinical Diagnostic Laboratories. HPV Self-Collection Screening (HPV-SCS) Ordering Recommendation The HPV Cervical Cancer Self-Collection Test is a highly sensitive screening tool that enables patients to collect their own vaginal sample using an FDA-approved device. After collection, the specimen is processed using advanced nucleic acid amplification methods (typically PCR-based) to qualitatively detect high-risk HPV DNA associated with cervical cancer. This self-collected approach offers comparable diagnostic accuracy to traditional clinician-collected samples while minimizing discomfort and barriers associated with pelvic examinations, making it an effective option for early detection and timely clinical follow-up. Mnemonic HPV Self-Collection Screening (HPV-SCS) Methodology The specimen is processed using nucleic acid amplification techniques (generally PCR-based methods) to qualitatively detect the presence of high-risk HPV DNA. Performed Mon-Sat Reported Within 3-5 days Specimen Required Patient Preparation: Collect: Wash your hands and remove the sterile self-collection device before gently inserting it into the vagina up to the indicated marker. Rotate the device 2–3 times as instructed to collect an adequate sample, then carefully withdraw it. Refrain from douching, using intravaginal medications, or applying topical agents for at least 48 hours prior to collection. • Avoid sexual intercourse for 24–48 hours before sample collection. • If menstruating, confirm with the provider whether sample collection should be postponed until menses have ceased. Specimen Preparation: Immediately place the collection device into the provided vial containing the appropriate viral transport medium. Secure the vial cap tightly and gently invert the vial to mix the specimen with the medium. Ensure that the specimen is labeled accurately with patient identification and collection date/time. Storage/Transport Temperature: Maintain at 2–8°C during storage and transport. Avoid freezing unless the test kit instructions specifically allow it. Prompt transport to the laboratory is advised to maintain sample integrity. Unacceptable Conditions: Specimens that are unlabeled or improperly labeled. Inadequate sample volume or insufficient cellular material. Contaminated samples (e.g., with menstrual blood or external substances) beyond acceptable limits. Specimens showing leakage or compromised container integrity. Samples exposed to temperatures outside the recommended range prior to processing Remarks: Specimen source required. Stability: Reference Interval Negative Interpretive Data A positive result should be correlated with clinical history and may necessitate additional diagnostic procedures. Careful patient education on follow-up steps and interpretation of results is essential. This test should be used as a screening tool only; abnormal findings must be evaluated in conjunction with other clinical assessments. Note CPT Code 87624 Aliases HPV Cervical Cancer Self-Collection Self-Collected HPV Test HPV DNA Test (Self-Collected) Cervical HPV Self-Sampling

Ordering information regarding a Tryptase test for Clinical Diagnostic Laboratories. Tryptase Ordering Recommendation Measure total tryptase to confirm mast cell activation in diseases such as mastocytosis, anaphylaxis, urticaria, and asthma. Not generally used acutely except where the diagnosis is unclear. Useful in the prognosis of systemic mastocytosis. Mnemonic EGGWHOLE Methodology Quantitative ImmunoCAP Fluorescent Enzyme Immunoassay Performed Mon-Sat Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Allow serum to clot completely at room temperature. Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.5 mL) Storage/Transport Temperature: Frozen. Unacceptable Conditions: Hemolyzed, icteric, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 72 hours; Frozen: 1 month Reference Interval Less than 11.0 µg/L Interpretive Data Compliance Category: FDA Note This test measures total tryptase and does not distinguish between the alpha and beta protein types. Samples should preferably be collected between 15 minutes and three hours after the event suspected to have caused mast cell activation. CPT Code 83520 Components Component Chart Name Tryptase Component Test Code 0099173 LOINC 21582-2 Aliases Total Tryptase Tryptase, Autopsy (Tryptase)